Abstract:The life-threatening fungal pathogens Cryptococcus neoformans and Cryptococcus gattii are differentiated from all other human fungal pathogens by the presence of a gelatinous capsule as well as an unusual underlying cell wall. These organisms have both been listed on the WHO list of fungal priority pathogens with higher disease burdens and unmet research and development needs, with C . neoformans at the top of the critical fungal priority group [1]. The aim of this review is to assess new insights into the unique attributes about Cryptococcus cell wall in relation to the pathogenic lifestyle of these important pathogens. Cryptococcus isolates have been classified into two species: C . neoformans (serotypes A, D, and AD) and C . gattii (serotypes B and C). Most studies on the Cryptococcus cell wall were performed using C . neoformans strains and, in many cases, without specifying the serotype used. For simplicity, here, I will only use the term " Cryptococcus " to indicate C . neoformans and C . gattii . Both the capsule and the cell wall contribute to the virulence properties of Cryptococcus and its ability to evade immune detection and killing (Table 1). The capsule and the cell wall are composed of different polysaccharides. While the capsule is mainly composed of glucuronoxylomannan and galactoxylomannan, the cell wall components include alpha- and beta-glucans, chitin, chitosan, and mannoproteins (Table 1). The capsule is an essential virulence factor of Cryptococcus , and, as a consequence, its synthesis and function have been extensively studied (reviewed in [2,3]). In contrast, little attention has been paid to the Cryptococcus cell wall and its role in pathogenesis. Yet, the cell wall plays a crucial role in capsule synthesis and organisation [4,5], and defects in the Cryptococcus cell wall result into dramatic defects in cell division and morphology, increased sensitivity to stresses, and reduced virulence [6–9]. These observations strongly indicate that the cell wall also plays an important role in the biology of Cryptococcus and is a driver of Cryptococcus infection and disease.

HISTOPATHOLOGY IN BOTRYOMYCOSIS‐LIKE PANOPHTHALMITIS DUE TO STAPHYLOCOCCUS AUREUS. A LIGHT MICROSCOPIC AND ELECTRON MICROSCOPIC STUDY:A Case Report

The buoyancy of cryptococcal cells and its implications for transport and persistence of Cryptococcus in aqueous environments

Human borna disease virus infection impacts host proteome and histone lysine acetylation in human oligodendroglia cells

Immobilization of cells by macro-porous NaCS-PDMDAAC capsules and cultivation in shaking flask and bubble bioreactor]

Quantum Algorithm for the Parity Problem

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Incidence, age distribution and complications of gonorrhoea in Sweden.

Color Blind Cellular Automata

Immunomodulatory Role of Capsular Polysaccharides Constituents of Cryptococcus neoformans

Leveraging a new data resource to define the response of C. neoformans to environmental signals

Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy.

No association between GSTM1 and GSTT1 genetic polymorphisms and susceptibility to opium sap dependence.

The Cryptococcus wall: A different wall for a unique lifestyle

Performance analysis of multistage interconnection networks with redundant links

Networks of fibers and factors: regulation of capsule formation in Cryptococcus neoformans

Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence

18F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma

A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer†.

Cryptococcus neoformans dual GDP-mannose transporters and their role in biology and virulence

Basic principles of the virulence of Cryptococcus